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Background: An estimated one million people worldwide die each year from complications of chronic hepatitis
B infection (CHB), including liver cancer. A disproportionate number of infections and deaths occur in China. The
incidence and mortality of liver cancer in Haimen City is among the highest in China, and in the world. A multi-year
citywide campaign was aimed at eliminating hepatitis B virus (HBV) infection and significantly reducing the number
of liver cancer deaths due to CHB in Haimen City, China.
Methods: Strategies included a public health information campaign targeting the 1.03 million city residents;
specialized health education for leaders and providers to increase adoption of evidence-based HBV management
protocols; establishment of health care infrastructure and management systems; and increased prevention and care
delivery to key subpopulations (especially pregnant women).
Results: The project developed and deployed broad-reaching public awareness and health education tools and
modules to 280,000 households and at community-based events. More than 90% of targeted healthcare providers
and 80% of the community leaders/government officials attended educational seminars during the project period
(1,441 health care providers; 1,883 local government officials). A centralized registration and management system
for pregnant women was developed and instituted, 100% of pregnant women were enrolled (5,407 women over
one year), and all infants born to HBV-infected mothers received one dose of HBIG and the first dose of HBV vaccine
by 24 hours of birth.
Conclusions: Lessons from the implementation phase of the project include the importance of: gaining early and
ongoing support from the local government and health bureau for success in reaching the targeted populations;
and having project management by a local, experienced, and trusted health expert to navigate implementation
and relationships, and help develop culturally and linguistically appropriate materials.
Keywords: Chronic hepatitis B infection, Hepatocellular carcinoma, Perinatal hepatitis B, Prevention, Health
education campaign, Hepatitis B screening, Hepatitis B vaccination, Haimen City, ChinaBackground
The burden of chronic hepatitis B infection in china
Worldwide, an estimated two billion people have been
infected with the hepatitis B virus (HBV) and, of these,
nearly 400 million remain chronically infected [1,2].
About one-third of those with chronic hepatitis B (CHB)
infection live in China, where it is estimated that around* Correspondence: chari.cohen@hepb.org
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unless otherwise stated.100 million people (about 10% of the Chinese population)
are chronically infected, and around 500,000 people die
from CHB-related complications, including primary liver
cancer (hepatocellular carcinoma, HCC) and cirrhosis,
each year [3-6]. China has the highest age-adjusted
incidence (new cases) of HCC due to CHB, and about
55% of liver cancer deaths worldwide occur in China [7].
Most of these deaths are men in their prime, between the
ages of 30 and 65 years. Up to 9.5% of Chinese women
of childbearing age have CHB [8]. Newborns infected
perinatally have a more than 90% risk of developingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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mature death from end-stage liver disease or liver
cancer [9,10]. Of babies born to HBV-infected mothers,
5% to 10% become chronically infected despite receiving
immunoprophylaxis with Hepatitis B immune globulin
(HBIG) and hepatitis B vaccine [11].
There are significant unmet needs for millions of indi-
viduals living with CHB, including a lack of screening
and diagnosis, and limited access to appropriate medical
care and treatment. The Hepatitis B Foundation (HBF)
believes that the burden of CHB can be reduced, and
lives saved, through improved public awareness, health
education, and screening. To this end, HBF launched the
“Gateway to Care Campaign: Haimen City Project” in
August 2010, in collaboration with the Haimen City
Center for Disease Control and Prevention (HCCDC).
This three-year project consisted of a targeted citywide
public health information campaign; specialized health
education and training for providers; establishment of
health care infrastructure and management systems; and
increased screening, vaccination, treatment, and care man-
agement service delivery to key subpopulations (especially
pregnant women and their infants and families).
The Haimen City cohort
Haimen City is located in Jiangsu Province, approximately
60 miles northwest of Shanghai, with a total population
of 1.03 million. HCC has been the leading cause of
cancer death in this population since 1970 (when death
registration began), and the incidence and mortality of
HCC in Haimen City are among the highest in China,
and in the world (Haimen City CDC Vital Statistics,
unpublished data). A landmark study of this population
published in 2006 clearly established a direct link between
hepatitis B viral load and subsequent risk of liver cancer in
chronically infected individuals [12]. This population-
based prospective cohort study, begun in 1992, enrolled
more than 90,000 Haimen City residents aged 25 to
64 years old. Blood tests for the presence of the hepa-
titis B surface antigen (HBsAg) indicated a 13.7% HBV
infection rate of the cohort. Intensive follow-up, including
annual collection and validation of vital statistics of each
cohort member, has been conducted since 1994. Between
1994 and 2007, there were 7,468 deaths in the cohort, of
which 1,717 (23%) were due to HCC.
Critical gaps in knowledge and practice
Previously published findings from this cohort have con-
tributed to global knowledge regarding the outcome of
chronic HBV infection. Although evidence-based HBV
prevention, treatment, and management protocols have
been published [13-17], evidenced-based guidelines have
not been implemented in Haimen City. Huge gaps in
knowledge and practice persist in the general population,among patients, and at every level of health care providers
in Haimen City. City public health officials estimate there
are approximately 80,000 people between the ages 25 to
64 years in Haimen City with CHB. Thousands will likely
die from HCC and other chronic liver diseases within the
next ten years if no appropriate actions are taken towards
the prevention and control of HBV in this population.
Methods
Project location and collaborators
Over the past two decades, Haimen City residents have
had high rates of participation in epidemiologic studies
of the impact of HBV on their population [12,18,19].
However, Haimen City (and much of China) still suffers
the stigma, loss of productivity, and death resulting
from hepatitis B. HBF saw a critical need to address the
significant burden of CHB through community-based
education and the creation of sustainable public health
services that could serve as a model for implementation
in other areas of China, and other high HBV-endemic
areas around the world. Excellent working relationships
between HBF and the HCCDC, the Haimen City Health
Bureau, Haimen City Center for the Health of Women
and Children (HCHWC), and the Haimen City Municipal
Government, made Haimen City an appropriate site for
this demonstration project. The HCCDC has an excellent
track record in public health awareness programming; the
recruitment and retention of study subjects; the collection
of high quality data and biological samples; and the train-
ing of doctors and other public health professionals whose
participation is needed to implement the project activities.
Specific benefits of conducting the campaign in Haimen
City included: immediate start-up of the project due to
existing infrastructure and relationships; timely government
approval of the program; comprehensive, well-organized
health care infrastructure; cooperation of healthcare offi-
cials; local experience in working with U.S. collaborators;
accurate data collection and credible results; and the poten-
tial for the transferability of the program to other small city
and rural populations.
Target populations
The public awareness component of the campaign was
designed to reach as many city residents as possible (total
1.03 million population, 280,000 households). A more
targeted educational outreach was directed toward city
and township government officials; school nurses; obste-
tricians and nurse assistants; public health officials and
physicians from 23 townships; village physicians from
239 villages; and community leaders from 239 villages.
In addition, because transmission of HBV from mother
to child during the perinatal period remains a serious
medical problem in China, the campaign sought to reach
all pregnant women over a one-year period; HBV-infected
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period; and spouses and first-degree relatives of HBV-
infected pregnant women.
Program goals and activities
The Gateway to Care Campaign has three primary goals
focused on public awareness, provider and leader educa-
tion, and elimination of perinatal transmission of HBV
(Table 1). Multi-platform educational campaigns for the
general public were developed and deployed, highlighting
the importance of being tested for HBV (see Additional
file 1). Specialized educational seminars were developed
for government officials, community leaders, and health-
care providers to increase their knowledge about HBV
infection and HCC, and foster appropriate testing and
referral to care. Finally, the project sought to increase
uptake by Chinese obstetrical and perinatal care providers
of improved, evidence-based methods to prevent and
manage perinatal HBV infection (see Table 1 for details
on strategies and targets). The educational materials,
training modules, survey questionnaires, and comprehen-
sive, multi-modal outcome evaluation plan were developed
together with the local project manager who is on staff at
the HCCDC (author PH).
Results and discussion
The implementation phase of the Haimen City project
concluded in July 2013. Figure 1 summarizes the outreach
activities and results for the three goals of public aware-
ness, provider and leader education, and elimination of
perinatal transmission. Overall, more than 90% of targeted
healthcare providers and 80% of the community leaders/
government officials attended educational seminars during
the project period (1,441 health care providers; 1,883 local
government officials; see Figure 1 for details).
A centralized registration and management system for
pregnant women was developed and instituted, and
5,407 pregnant women were registered and screened for
hepatitis B between July 1, 2011 and June 30, 2012 (see
Figure 1). A total of 266 women (4.9%) tested positive
for HBsAg, and all 246 infants (100%) born to these
HBV-infected mothers received one dose of HBIG and
the first dose of HBV vaccine by 24 hours of birth. For
comparison, an associated retrospective survey found that,
of 180 infants born to HBV-infected mothers in Haimen
City in 2010, 178 (98.9%) had received the first dose of
HBV vaccine after birth, but only 128 infants (71.1%) had
received HBIG (Haimen City CDC unpublished data).
Hepatitis B-related knowledge change in health care
providers, health officials, and community leaders who
attended educational events will be evaluated using data
from pre- and post-tests conducted before and immediately
after educational events, and two years after the launch
of the campaign (to determine sustainability of change).The long-term impact of the project overall (sustainability
of knowledge improvements, behavior change, systemic
effects of the program/policy changes in Haimen City) will
be assessed via focus groups, interviews, and surveys
conducted at 1 and 3 years post-project completion. Data
collection from the prospective study to evaluate perinatal
prophylaxis failure is ongoing, and will be analyzed
according to the approved study protocol.
Conclusions
To our knowledge, this citywide awareness campaign
designed to reach all 1.03 million Haimen City residents
and their healthcare providers is the first of its kind
addressing hepatitis B in China. Through its Gateway
to Care initiative, HBF hopes to increase public awareness
and health care provider knowledge about HBV prevention,
screening, and care; expand HBV screening of pregnant
women and ensure post-exposure prophylaxis of newborns;
and foster adoption of evidence-based HBV management
protocols. The HBF and HCCDC will continue to monitor
the effects of the program for the next ten years, tracking
expected reductions in deaths from CHB and HCC in
the population of Haimen City. It is expected that
increasing public awareness about hepatitis B will also
help to dispel myths, and decrease the stigma and
discrimination associated with this chronic and highly
prevalent disease. The research findings about HBV know-
ledge and practices will contribute to the development
of effective educational strategies for target audiences.
These findings will also inform policy changes toward
the improvement of health care outcomes in individuals
with CHB, and the elimination of new HBV infections in
China and other areas of the world where HBV is endemic.
Deployment of the tools developed for this project, includ-
ing the educational materials and the database system for
registration and management of pregnant women, can also
be expanded to other regions where HBV is endemic.
Several practical elements of the development and im-
plementation phases of this project were contributors to
its success thus far. Involving key stakeholders, including
the Haimen City municipal government, the health bureau,
and prominent physicians, at the beginning of the project
was critical for success in reaching out to the targeted
population in a project of this scale. HBF has established
and maintained communication with the Chinese Founda-
tion for Hepatitis Prevention and Control, in partnership
with Haimen City government and public health officials,
to pave the way for policy changes based on current and
forthcoming project data. Project management conducted
at the local level by an experienced and trusted member
of the local health care community was extremely helpful
for navigating implementation in Haimen City and its
villages. (In this case the Deputy Director at the HCCDC
was recruited as the project manager.) The onsite project
Table 1 Gateway to care campaign: Haimen city project goals, srategies and targets
Goals
1) Raise public awareness 2) Educate providers and leaders 3) Prevent perinatal transmission
Implement a citywide public health
information campaign to increase
understanding and acceptance of
current knowledge about hepatitis and
liver cancer among the general public.
Educate government officials, community
leaders, and healthcare providers to
increase their knowledge about hepatitis
B and liver cancer.
Initiate evidence-based practices for pregnant
women to prevent perinatal transmission of
hepatitis B and to ensure appropriate care
and referral of chronically infected women.
Strategies
• Initiate a culturally competent public
awareness campaign to inform the public
about hepatitis B and the importance of
prevention, screening and management of
this serious liver infection in partnership with
the Haimen City Health Bureau and HCCDC.
• Educate city and township government
officials to gain their support of public health
programs. Work with Haimen City government
to present seminars to city and township
officials who can play an important role in
supporting critical public health initiatives, and
in reducing social stigma and discrimination.
• Evaluate current practices in perinatal care
for HBV-infected and non-infected pregnant
women. Work with HCCHWC to retrospectively
review HBV testing, follow-up, and antepartum
treatment of 1,000 pregnant women, and
passive-active immunization of neonates after
birth ( including completion rates of the three
shot series)• Disseminate information in partnership with
and through the comprehensive HCCDC
network of city hospitals, city and township
health centers, and village doctors.
• Educate community leaders to gain their
support of public health programs. Work with
HCCDC to present seminars to the village head,
party secretary, accountant, and women’s
representatives from 239 villages in Haimen City
who will, in turn, distribute educational
materials to residents of their villages.
• Establish a centralized registration, and
management system for all pregnant women
in the city to ensure appropriate screening and
care. Work with HCCHWC to create an interactive
system to register and estimated 6,000 pregnant
women in the city, and input data from
HBV-positive women and their newborns.
• Create simple and appealing educational
literature, posters and interactive materials
(e.g., calendars, posters, playing cards, paper
cups). Coordinate media outreach through
print, televisions, and broadcast outlets to
include news articles, personal stories, and
community events. Key message: hepatitis B
can lead to liver cancer, but it can be
prevented with a safe vaccine and managed
with effective treatments.
• Educate township-level public health officials
and physicians to emphasize the importance
of testing and referral to care. Develop health
education curricula and work with HCCDC to
present seminars to public health officials and
physicians at township-level health care centers
and hospitals.
• Conduct a prospective study to evaluate failures
of perinatal immunoprophylaxis (HBIG and HBV
vaccine). HBV DNA quantitation will be used to
determine if there is any correlation between
high maternal viral load and perinatal
prophylactic failure.
• Develop targeted educational materials
for individuals with CHB to increase their
knowledge about hepatitis B and liver cancer
and encourage them to seek and
maintain regular care.
• Educate community-based physicians
about importance of prevention, screening,
management, and referral to liver specialists.
Work with HCCDC to present seminars to
village doctors from 239 villages.
• Develop a standard protocol to educate and
test spouses and relatives of all pregnant women.
Education will be provided to family members to
increase their knowledge about HBV abd reduce
the social stigma of hepatitis B.
• Educate school nurses about HBV transmission,
vaccination of susceptible children, and
preventing discrimination against infected
children. Work with the Haimen City Educational
Bureau to present seminars to school nurses at
primary and secondary schools in the city.
• Educate obstetricians and midwives about
prevention of perinatal HBV transmission. Work
with HCCHWC to present seminars to obstetrical
providers in the city. Develop evidence-based
screening, vaccination, and HBV management
guidelines for pregnant women.
Targets
Disease awareness information distribution
to healthcare centers and administrative
buildings in all 239 villages, as well as
hospitals, and health service centers in
all 23 townships.
At least 90% of government officials and
community leaders and 100% of village
doctors, obstetricians, and school nurses
will have attended at least one formal
education session.
100% of newly registered pregnant women
screened for HBV and infected women
followed under evidence-based protocols
over a 12-month period. 100% of newborns
to receive HBV vaccine and HBIG with 12 hours
of birth. 100% of infants born to infected
mothers to receive HBV vaccine and HBIG
within 12 hours of birth.
CHB, chronic hepatitis B infection; HBIG, hepatitis B immune globulin; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCCDC, Haimen City Center for
Disease Control; HCCHWC, Haimen CIty Center for the Health of Women and Children.
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Figure 1 Overview of outreach activities. Numbers and proportion of Haimen city residents, city leaders, health care providers, and pregnant
women reached during the implementation phase of the project.
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assured that milestones were met in a timely fashion,
oversaw data collection and evaluation, worked with
media outlets to promote the campaign, and interacted
with the city public health and government leaders.
Also essential was the development of culturally and
linguistically appropriate, relevant, and potentially effect-
ive educational materials, training modules, and survey
questionnaires. The local project manager and other key
local experts are important resources for this task.
Ethics statement
This program was reviewed and approved by the Medical
Ethics Review Committee of Haimen City. No identifying
or individual level data were collected as part of the
demonstration (education) component of the program,
thus the ethics committee considered this component
to be exempt from full review.
Additional file
Additional file 1: Community awareness campaign logo. Residents
of Haimen City received free hepatitis B education at community events
and also through printed media and mailings. At community awareness
events held in 2011, three hepatologists from the Infectious Disease
Department of Haimen City People’s Hospital and three project staff from
the HCCDC answered questions and distributed educational give-away
items, including brochures and playing cards. All materials were branded
with the program logo, seen here, which includes the messages “Right
Knowledge, Right Action” and “Stopping Liver Cancer Starts from
Prevention and Treatment of Hepatitis B.”Abbreviations
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Foundation; (HCCDC): Haimen City Center for Disease Control and
Prevention; (HBsAg): Hepatitis B surface antigen; (HCHWC): Haimen City
Center for the Health of Women and Children; (HCC): Hepatocellular
carcinoma; (HBIG): Hepatitis B immune globulin.
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